miR-126 mitigates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting the ERK1/2 and Bcl-2 pathways

• Published in: Acta biochimica et biophysica Sinica 2023-03, Vol.55 (3), p.449-459
• Main Authors: Zhang, Ying, Dong, Yiping, Wei, Qiushi, Zhuang, Zhikun, Liu, Youwen, Yuan, Qiang, He, Wei, Jing, Zhenhao, Li, Jitian, Li, Peifeng, Zhang, Leilei, Hong, Zhinan, Zhang, Ning, Wang, Haibin, Li, Wuyin
• Format: Article
• Language: English
• Subjects: Bcl-2; Bone Marrow - metabolism; Bone Marrow Cells - metabolism; Cell Differentiation - genetics; Cells, Cultured; ERK1/2; hBMMSCs; Humans; Inflammation - metabolism; MAP Kinase Signaling System - genetics; Mesenchymal Stem Cells - metabolism; MicroRNAs - metabolism; miR-126; Osteogenesis - genetics; osteogenic differentiation
• ISSN: 1672-9145; 1745-7270
• DOI: 10.3724/abbs.2023016

Human bone marrow mesenchymal stem cells (hBMMSCs) are a promising cell source for bone engineering owing to their high potential to differentiate into osteoblasts. The objective of the present study is to assess microRNA-126 (miR-126) and examine its effects on the osteogenic differentiation of hBMMSCs. In this study, we investigate the role of miR-126 in the progression of osteogenic differentiation (OD) as well as the apoptosis and inflammation of hBMMSCs during OD induction. OD is induced in hBMMSCs, and matrix mineralization along with other OD-associated markers are evaluated by Alizarin Red S (AR) staining and quantitative PCR (qPCR). Gain- and loss-of-function studies are performed to demonstrate the role of miR-126 in the OD of hBMMSCs. Flow cytometry and qPCR-based cytokine expression studies are performed to investigate the effect of miR-126 on the apoptosis and inflammation of hBMMSCs. The results indicate that miR-126 expression is downregulated during the OD of hBMMSCs. Gain- and loss-of function assays reveal that miR-126 upregulation inhibits the differentiation of hBMMSCs into osteoblasts, whereas the downregulation of miR-126 promotes hBMMSC differentiation, as assessed by the determination of osteogenic genes and alkaline phosphatase activity. Furthermore, the miR-126 level is positively correlated with the production of inflammatory cytokines and apoptotic cell death. Additionally, our results suggest that miR-126 negatively regulates not only B-cell lymphoma 2 (Bcl-2) expression but also the phosphorylation of extracellular signal‑regulated protein kinase (ERK) 1/2. Moreover, restoring ERK1/2 activity and upregulating Bcl-2 expression counteract the miR-126-mediated suppression of OD in hBMMSCs by promoting inflammation and apoptosis, respectively. Overall, our findings suggest a novel molecular mechanism relevant to the differentiation of hBMMSCs into osteoblasts, which can potentially facilitate bone formation by counteracting miR-126-mediated suppression of ERK1/2 activity and Bcl-2 expression.